Form D · Other Technology
REBUS BIOSYSTEMS, INC.
Santa Clara, CA · CIK 0001393853
Offering snapshot reported Nov 3, 2022 · SEC filing
- Reported sold
- $17.8M Offering amount: $32.3M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 28, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 3, 2022 | Initial | $17,761,424 | No comparison | 6 | SEC filing |
| Sep 19, 2012 | Initial | $5,082,474 | No comparison | 6 | SEC filing |
| Mar 26, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 19, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-463802
Source: Form D, filed Nov 3, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hyon Yong Chong | Director |
| Ronald M. Cook | Director |
| Chang Seuk Hwang | Director |
| Tae Hoon Nahm | Director |
| Dongwoo Nahm | Director |
| Jekwan Ryu | Director, Executive |
| Jeongsun Seo | Director |
| Eric Williams | Executive |
| Tom Willis | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2255 Martin Avenue Ste F
Santa Clara, CA, 95050
Santa Clara, CA, 95050